NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $500,000 | +8.9% | 5,279 | 0.0% | 0.41% | +2.2% |
| Q3 2019 | $459,000 | -1.5% | 5,279 | 0.0% | 0.40% | -1.7% |
| Q2 2019 | $466,000 | -8.3% | 5,279 | 0.0% | 0.41% | -8.1% |
| Q1 2019 | $508,000 | +12.1% | 5,279 | 0.0% | 0.44% | +3.7% |
| Q4 2018 | $453,000 | -0.4% | 5,279 | 0.0% | 0.43% | +15.1% |
| Q3 2018 | $455,000 | +14.0% | 5,279 | 0.0% | 0.37% | +21.2% |
| Q2 2018 | $399,000 | -99.9% | 5,279 | 0.0% | 0.31% | -17.1% |
| Q1 2018 | $426,807,000 | +95382.6% | 5,279 | 0.0% | 0.37% | +2.5% |
| Q4 2017 | $447,000 | – | 5,279 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |